Quantcast

Latest Tumors Stories

2014-09-15 23:11:36

A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important step toward answering the question: which altered genes are most to blame for bladder cancer? AURORA, Colo. (PRWEB) September 15, 2014 The story of cancer care seems so simple: find the mutated gene that causes cancer and turn it off or fix it. But rarely does a single gene cause cancer....

2014-08-28 08:27:58

SAN ANTONIO, Aug. 28, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the recent publication of the article "Targeting thapsigargin towards tumors" in the journal Steroids. The recent article co-authored by Doan, et al. (see full reference below), reviews the evolution and development of GenSpera's prodrug technology platform that is designed to deliver the potent, cytotoxic activity of...

2014-08-21 12:29:29

The Jeffrey Epstein VI Foundation funds a study showing tumor growth. NEW YORK, Aug. 21, 2014 /PRNewswire/ -- Mathematic studies at the Program for Evolutionary Dynamics (PED) at Harvard University, and funded by the Jeffrey Epstein VI Foundation, have shown that the most aggressive cells within tumors can be visually identified for elimination. These aggressive cells are the driver mutations that drive the tumor's growth. The study, which shows a topological map of what to look for...

2014-08-08 11:20:47

Cell Transplantation Center of Excellence for Aging and Brain Repair Induced immunorejection may eliminate tumors post-cell transplantation Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs is the potential for tumor growth, or tumorogenesis, post-transplantation. In an...

2014-08-04 09:29:32

Washington University School of Medicine New research at Washington University School of Medicine in St. Louis helps explain why brain tumors occur more often in males and frequently are more harmful than similar tumors in females. For example, glioblastomas, the most common malignant brain tumors, are diagnosed twice as often in males, who suffer greater cognitive impairments than females and do not survive as long. The researchers found that retinoblastoma protein (RB), a protein...

2014-07-28 10:33:11

Dartmouth-Hitchcock Norris Cotton Cancer Center Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center are exploring ways to wake up the immune system so it recognizes and attacks invading cancer cells. Tumors protect themselves by tricking the immune system into accepting everything as normal, even while cancer cells are dividing and spreading. One pioneering approach, discussed in a review article published this week in WIREs Nanomedicine and Nanobiotechnology, uses...

2014-07-10 12:22:20

Fox Chase Cancer Center Study Finds that Some Women Do Better than Current Staging Guidelines Suggest New findings from Fox Chase Cancer Center paint a relatively optimistic picture of women’s chances of surviving a subset of breast cancers that have spread to the chest wall or skin, but not beyond. Tumors that grow into the skin, regardless of size and whether they have involved lymph nodes, are automatically classified as stage III – and called “locally advanced” tumors,...

Allergy Medications May Be The Next Class Of Cancer Fighting Drugs
2014-07-01 15:14:58

Rebekah Eliason for redOrbit.com – Your Universe Online In a surprising discovery, researchers have noticed that the same kinds of drugs that relieve watery eyes and runny noses from allergies can also help fight off tumors. This new report suggests that antihistamines could have significant anti-cancer properties. These types of drugs interfere with the cell function “myeloid derived suppressor cells” that is known to reduce the body’s ability to fight tumors. "This research is...

2014-06-18 23:13:01

PeptiMed, a biopharmaceutical company focused on novel mechanisms of drug delivery, is pleased to announce the allowance of its claims for a targeted elastin-like polypeptide (ELP) nanoparticle for delivery of nucleotide therapeutic agents. Madison, Wisconsin (PRWEB) June 18, 2014 PeptiMed announced today that it was awarded United States patent No. 8,680,045, entitled, “Compositions of a peptide targeting system for treating cancer.” The invention describes a protein nanoparticle...

2014-06-11 08:29:54

All 9 Out Of 9 Patients Who Have Reached 4 Injections Are Showing Tumor Cell Death, Tumor Shrinkage And/Or Stabilization Of Disease BETHESDA, Md., June 11, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that, in the ongoing Phase I/II clinical trial of DCVax-Direct for all types of inoperable solid tumors, all 9 out of 9 patients who have...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related